Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 15Colorectal Neoplasms 13Lung Neoplasms 12Neoplasms 11Stomach Neoplasms 9Neoplasm Metastasis 6Colonic Neoplasms 6Esophageal Neoplasms 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Osteosarcoma 3Multiple Myeloma 3Melanoma 3Lymphoma, Follicular 3Lymphoma 3Waldenstrom Macroglobulinemia 2Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Thymus Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Rectal Neoplasms 2

Interventions

ezogabine 1camrelizumab 1apatinib 1Metabolic Networks and Pathways 1Drug Therapy, Combination 1Drug Therapy 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Advanced Gastric Cancer × Drug Therapy × Clear all
NCT06727981 2024-12-11

First-Line and Neoadjuvant Immunotherapy for Gastric Cancer

Qilu Hospital of Shandong University

Recruiting
500 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡